{
  "id": 112162,
  "title": "#Aids2026: Three HIV announcements South Africa made in Rio",
  "url": "https://urgent.news/2026/08/04/aids2026-three-hiv-announcements-south-africa-made-in-rio",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-04T02:30:00.000Z",
  "source": {
    "name": "Bhekisisa",
    "slug": "bhekisisa",
    "url": "https://bhekisisa.org/health-news-south-africa/2026-08-04-aids2026-three-hiv-announcements-south-africa-made-in-rio/"
  },
  "original_language": "en",
  "account": null,
  "summary": "South Africa unveiled a new dashboard to track the roll-out of HIV prevention medicine at the International Aids Conference in Rio, with nearly 36,000 HIV-negative people having taken the six-monthly injection, Lenacapavir (LEN), by August 3rd. Of these, a quarter were pregnant or breastfeeding women, a high-risk group for HIV transmission. Aspen Pharmacare secured a licence to manufacture a promising monthly HIV prevention pill, beating the requirement of pre-study data, while progress towards local manufacturing of LEN is underway, with a shortlist of potential producers now in Gilead Sciences’ hands.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}